Small Molecules

A new publication will give the small molecule manufacturing community the attention and praise it deserves. Meet The Small Molecule Manufacturer.

ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.

A battery-like system developed by scientists at Scripps Research could help enhance the manufacture of drugs.

The potential market for complex generics is substantial, but navigating the FDA’s guidance for proving “sameness” is a real minefield...

Douglas J. Swirsky, CEO of Rexahn Pharmaceuticals, explains his company’s approach to developing more effective cancer treatments.

The inventor of ibuprofen died on January 30, aged 95.

David Walker discusses the threat of bioterrorism and the importance of basic research.

Emergent Biosolutions, has become a multinational biopharma company, despite working in some difficult therapeutic areas including biodefense.

Industry 4.0 is making progress and should encourage the adoption of new technologies.

A new automated chemical synthesis machine aims to remove some of the repetitive processes from a scientist’s day.